"
Our revenues were approximately $1.8 million and $3.4 million for the three and six months ended June 30, 2018, respectively, compared to revenues of $2.0 million and $4.5 million for the three and six months ended June 30, 2017, respectively. We derived approximately 68% of our revenues from the United States for the six months ended June 30, 2018, compared to 76% for the six months ended June 30, 2017. We derived approximately 30% of our revenues from Europe for the six months ended June 30, 2018, compared to 24% for the six months ended June 30, 2017. The remaining 2% in revenues originated in Latin America and Asia Pacific for the six months ended June 30, 2018. We placed 21 and 44 units during the three and six months ended June 30, 2018, respectively, compared to 31 and 68 units during the three and six months ended June 30, 2017, respectively. As of June 30, 2018, there were 250 pending
insurance claims relating to coverage for ReWalk, compared to 217 as of June 30, 2017.
Our cash and cash equivalents were approximately $9.1 million as of June 30, 2018, compared to $16.3 million as of June 30, 2017 and $14.6 million as of December 31, 2017."
http://ir.rewalk.com/static-files/27e27186-6e95-4f13-a678-c7f9fcb58379
I am long on RWLK and I will not be surprised to hear pleasant updates tomorrow but Q2 numbers will not be great.
Recent RWLK News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/29/2024 12:30:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 08:16:29 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 08:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/19/2024 12:46:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/04/2024 01:01:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2024 11:34:09 AM
- VA STAND Act introduced in the United States Senate • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- Lifeward Announces Reverse Share Split • GlobeNewswire Inc. • 03/13/2024 03:45:17 PM
- ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy • GlobeNewswire Inc. • 03/08/2024 01:30:00 PM
- Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may b • GlobeNewswire Inc. • 03/01/2024 01:45:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 02:15:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:15:25 PM
- Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 01:00:07 PM
- Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/20/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:15:24 PM
- ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward • GlobeNewswire Inc. • 01/29/2024 01:00:00 PM
- ReWalk Robotics Expands Direct Sales Coverage to Canada • GlobeNewswire Inc. • 01/12/2024 01:30:00 PM
- ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17 • GlobeNewswire Inc. • 01/11/2024 10:00:06 PM
- First ReWalk Personal Exoskeleton Claim Paid by Medicare • GlobeNewswire Inc. • 01/05/2024 01:00:00 PM
- ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities • GlobeNewswire Inc. • 01/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:04:05 PM
- ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting • GlobeNewswire Inc. • 11/30/2023 09:45:00 PM
- ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype • GlobeNewswire Inc. • 11/28/2023 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:37:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/20/2023 11:39:22 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM